Critical Care

official impact factor 4.60

Open Access Highly Access Email this article to a friend

Drotrecogin alfa (activated): real-life use and outcomes for the UK

Kathryn M Rowan*, Catherine A Welch, Emma North and David A Harrison

Critical Care 2008, 12:R58 doi:10.1186/cc6879

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.